Abstract Hot flashes (HF) are a common adverse event of prolonged tamoxifen use in women with estrogen receptor-positive breast cancer. impacting psychiatric health and quality of life. While desvenlafaxine does not interact with tamoxifen. its efficacy and safety in breast cancer patients remain unstudied. https://www.spidertattooz.com/JuneShine-Prickly-Weekend-Friend-16oz-can-6-ABV/
Differential effects of desvenlafaxine on hot flashes in women with breast cancer taking tamoxifen: a randomized controlled trial
Internet 3 hours ago ojthbqs0ph3nWeb Directory Categories
Web Directory Search
New Site Listings